Medications

US approves Regeneron antibody treatment given to Trump

A COVID-19 antibody therapy used to treat President Donald Trump was approved by the US drug regulator on Saturday for people who aren't yet hospitalized by the disease but are at high risk.

Oncology & Cancer

Study examines trends in esophageal cancer disparities over time

From 1999 to 2020, age-adjusted esophageal cancer mortality decreased among Black adults but stabilized among white adults, reducing the racial mortality gap, according to a study published online July 24 in the Journal of ...

page 13 from 40